
Jefferies slashes Agilon Health stock, shares investor skepticism
On Monday, Jefferies initiated coverage on Agilon Health Inc (NYSE:AGL) stock with a Hold rating. The analyst significantly reduced the price target to $6.50 from the previous target of $25.00. \"We share investor skepticism on FY24 guidance but see potential LT upside even if EBITDA falls short of the guide.\" said the analyst. He noted...